Involvement of a Glutamatergic Mechanism in δ-Dendrotoxin-Induced Hippocampal Neuronal Cell Loss in the Rat

$48.00 plus tax (Refund Policy)

Download / Buy Article:

Abstract:

Abstract:

The epileptogenic and neurodegenerative effects of δ-dendrotoxin, from Dendroaspis angusticeps, a specific blocker of a non-inactivating, voltage-sensitive K+ channel, were studied after focal injection into one dorsal hippocampus in rats pretreated with CGP040116, a N-methyl-D-aspartate (NMDA) receptor antagonist, and in rats bearing a monolateral surgical lesion of the Schaffer collaterals whose terminals originate from CA3 pyramids and release glutamate in the CA1 hippocampal area. Administration of 35 pmol δ-dendrotoxin elicited in all of the treated animals (n=8) bilateral EEG discharges and damage to the hippocampal formation. Quantitation of the damage revealed significant bilateral neuronal cell loss in the CA1, CA3 and CA4 pyramidal cell layers. The lowest dose (0.35 pmol; n=4) of the toxin used did not affect EEG activity and failed to cause significant hippocampal cell loss whereas the 3.5 pmol (n=6) dose caused EEG seizures and hippocampal cell loss limited to the CA1 area. Systemic intraperitoneal administration of CGP040116 (5 mg/kg given 30 min. previously) delayed the onset of EEG seizures and reduced the number of epileptogenic discharges typically observed in rats receiving an injection of δ-dendrotoxin (35 pmol) alone. Similarly, this treatment prevented the damage inflicted to the hippocampus by the toxin and in no instance was significant neuronal loss observed. Protection against seizures and hippocampal damage was also observed by a monolateral surgical lesion to the Schaffer collaterals. In conclusion, the present data suggest that an excitotoxic, glutamate-mediated, type of mechanism underlies seizures and hippocampal damage induced by δ-dendrotoxin in rats.

Document Type: Research Article

DOI: http://dx.doi.org/10.1111/j.1742-7843.2004.pto940306.x

Affiliations: 1: Department of Pharmacobiological Sciences, University Magna Graecia of Catanzaro, Catanzaro, Italy 2: IRCCS C. Mondino, Pavia and Experimental Neurobiology Center Mondino-Tor Vergata-Santa Lucia, Rome; 3: Department of Pharmacobiology, University of Calabria at Cosenza 4: Imperial College of Science, Technology and Medicine, London, U.K.

Publication date: March 1, 2004

More about this publication?
  • Formerly Pharmacology & Toxicology

Tools

Favourites

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more